skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Cumulative dose of radiation therapy of hepatocellular carcinoma patients and its deterministic relation to radiation-induced liver disease

Journal Article · · Medical Dosimetry
;  [1];  [2];  [3]; ; ; ;  [4];  [5];  [1];  [6];  [2];  [4];  [2];  [1]
  1. Shandong Province Key Laboratory of Medical Physics and Image Processing Technology, Institute of Biomedical Sciences, School of Physics and Electronics, Shandong Normal University, Jinan, Shandong (China)
  2. Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA (United States)
  3. Jinan Municipal Center for Disease Control and Prevention of Shandong Province, Jinan, Shandong (China)
  4. Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Jinan, Shandong (China)
  5. Department of Radiation Oncology, Qingdao University Medical College Affiliated Yantai Yuhuangding Hospital, Yantai (China)
  6. Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen (China)

This study aimed to investigate the relationship between dose and radiation-induced liver disease (RILD) in patients with hepatocellular carcinoma (HCC) receiving 3-dimensional conformal radiotherapy (3DCRT). Twenty-three patients with HCC who received conventional fractionated 3DCRT, including 7 who were diagnosed with classic RILD, were enrolled in this retrospective investigation. Cone-beam computed tomography (CBCT) scans were acquired at the time of treatment for each patient. The beams from each patient's treatment plan were applied to each pretreatment CBCT (the modified CBCT or mCBCT) to construct the delivered dose distribution of the day considering inter-treatment anatomy changes. The daily doses were summed together with the help of deformable image registration (DIR) to obtain the adjusted cumulative dose (D{sub adjusted}). The dose changes to the normal liver between the original planned dose (D{sub plan}) and D{sub adjusted} were evaluated by V20, V30, V40, and the mean dose to normal liver (MDTNL). Univariate analysis was performed to identify the significant dose changes. Among the 23 patients, the liver V20, V30, V40, and MDTNL showed significant differences between D{sub plan} and D{sub adjusted}, with average values of these parameters increased by 4.1%, 4.7%, 4.5%, and 3.9 Gy, respectively (p adjusted. Determination of a reconstructed D{sub adjusted} using the mCBCT scans are more accurate in predicting RILD and has the potential to reduce the risk of RILD.

OSTI ID:
22824203
Journal Information:
Medical Dosimetry, Vol. 43, Issue 3; Other Information: Copyright (c) 2017 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0958-3947
Country of Publication:
United States
Language:
English